Stemline Therapeutics Inc (NASDAQ:STML)

17.30
Delayed Data
As of Apr 20
 +0.10 / +0.58%
Today’s Change
7.30
Today|||52-Week Range
18.75
+10.90%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Stemline Therapeutics Inc have a median target of 34.50, with a high estimate of 41.00 and a low estimate of 19.00. The median estimate represents a +99.42% increase from the last price of 17.30.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Buy stock in Stemline Therapeutics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.58
Sales
$249.5K
Reporting Date
May 15

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 37.63%
 
 
 
 
 
 
Growthannually 0.26%
 
 
 
 
 
 

Sales

Growthquarterly -16.67%
 
 
 
 
 
 
Growthannually 1,338.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.